Raptiva: Genentech Pulls Drug From Market For Safety
SOUTH SAN FRANCISCO, Calif. — The Genentech unit of drugmaker Roche Holding AG is pulling the psoriasis treatment Raptiva off the U.S. market be...
SOUTH SAN FRANCISCO, Calif. — The Genentech unit of drugmaker Roche Holding AG is pulling the psoriasis treatment Raptiva off the U.S. market be...
AP | ALEXANDER G. HIGGINS | Posted 05.25.2011
GENEVA — Swiss pharmaceutical giant Roche agreed to pay $46.8 billion to buy the 44 percent of biotech pioneer Genentech that it doesn't already...
Wall Street Journal | RON WINSLOW | Posted 11.17.2011
New research at Genentech Inc. is challenging conventional thinking about Alzheimer's disease, providing a provocative theory about its cause and sugg...
Lauren Cahn | Posted 11.17.2011
Maybe a reality check isn't something you want when you're being bombarded with "Breast Cancer Awareness" messages. After all, that would be kind of scary.
New York Times | David Jolly | Posted 05.25.2011
PARIS -- The Swiss drug maker Roche Holding said Monday that it was offering about $43.7 billion to acquire the 44 percent of the biotechnology compan...
Fortune | Jon Birger and Katie Benner | Posted 05.25.2011
We'll say this for the U.S. economy: It can take a punch. Consider the blows it has absorbed just this year. The worst real estate crash since the Gr...
AP | Posted 05.25.2011